Cargando…

C-Terminal Region of EBNA-2 Determines the Superior Transforming Ability of Type 1 Epstein-Barr Virus by Enhanced Gene Regulation of LMP-1 and CXCR7

Type 1 Epstein-Barr virus (EBV) strains immortalize B lymphocytes in vitro much more efficiently than type 2 EBV, a difference previously mapped to the EBNA-2 locus. Here we demonstrate that the greater transforming activity of type 1 EBV correlates with a stronger and more rapid induction of the vi...

Descripción completa

Detalles Bibliográficos
Autores principales: Cancian, Laila, Bosshard, Rachel, Lucchesi, Walter, Karstegl, Claudio Elgueta, Farrell, Paul J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3145799/
https://www.ncbi.nlm.nih.gov/pubmed/21857817
http://dx.doi.org/10.1371/journal.ppat.1002164
_version_ 1782209131657035776
author Cancian, Laila
Bosshard, Rachel
Lucchesi, Walter
Karstegl, Claudio Elgueta
Farrell, Paul J.
author_facet Cancian, Laila
Bosshard, Rachel
Lucchesi, Walter
Karstegl, Claudio Elgueta
Farrell, Paul J.
author_sort Cancian, Laila
collection PubMed
description Type 1 Epstein-Barr virus (EBV) strains immortalize B lymphocytes in vitro much more efficiently than type 2 EBV, a difference previously mapped to the EBNA-2 locus. Here we demonstrate that the greater transforming activity of type 1 EBV correlates with a stronger and more rapid induction of the viral oncogene LMP-1 and the cell gene CXCR7 (which are both required for proliferation of EBV-LCLs) during infection of primary B cells with recombinant viruses. Surprisingly, although the major sequence differences between type 1 and type 2 EBNA-2 lie in N-terminal parts of the protein, the superior ability of type 1 EBNA-2 to induce proliferation of EBV-infected lymphoblasts is mostly determined by the C-terminus of EBNA-2. Substitution of the C-terminus of type 1 EBNA-2 into the type 2 protein is sufficient to confer a type 1 growth phenotype and type 1 expression levels of LMP-1 and CXCR7 in an EREB2.5 cell growth assay. Within this region, the RG, CR7 and TAD domains are the minimum type 1 sequences required. Sequencing the C-terminus of EBNA-2 from additional EBV isolates showed high sequence identity within type 1 isolates or within type 2 isolates, indicating that the functional differences mapped are typical of EBV type sequences. The results indicate that the C-terminus of EBNA-2 accounts for the greater ability of type 1 EBV to promote B cell proliferation, through mechanisms that include higher induction of genes (LMP-1 and CXCR7) required for proliferation and survival of EBV-LCLs.
format Online
Article
Text
id pubmed-3145799
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-31457992011-08-19 C-Terminal Region of EBNA-2 Determines the Superior Transforming Ability of Type 1 Epstein-Barr Virus by Enhanced Gene Regulation of LMP-1 and CXCR7 Cancian, Laila Bosshard, Rachel Lucchesi, Walter Karstegl, Claudio Elgueta Farrell, Paul J. PLoS Pathog Research Article Type 1 Epstein-Barr virus (EBV) strains immortalize B lymphocytes in vitro much more efficiently than type 2 EBV, a difference previously mapped to the EBNA-2 locus. Here we demonstrate that the greater transforming activity of type 1 EBV correlates with a stronger and more rapid induction of the viral oncogene LMP-1 and the cell gene CXCR7 (which are both required for proliferation of EBV-LCLs) during infection of primary B cells with recombinant viruses. Surprisingly, although the major sequence differences between type 1 and type 2 EBNA-2 lie in N-terminal parts of the protein, the superior ability of type 1 EBNA-2 to induce proliferation of EBV-infected lymphoblasts is mostly determined by the C-terminus of EBNA-2. Substitution of the C-terminus of type 1 EBNA-2 into the type 2 protein is sufficient to confer a type 1 growth phenotype and type 1 expression levels of LMP-1 and CXCR7 in an EREB2.5 cell growth assay. Within this region, the RG, CR7 and TAD domains are the minimum type 1 sequences required. Sequencing the C-terminus of EBNA-2 from additional EBV isolates showed high sequence identity within type 1 isolates or within type 2 isolates, indicating that the functional differences mapped are typical of EBV type sequences. The results indicate that the C-terminus of EBNA-2 accounts for the greater ability of type 1 EBV to promote B cell proliferation, through mechanisms that include higher induction of genes (LMP-1 and CXCR7) required for proliferation and survival of EBV-LCLs. Public Library of Science 2011-07-28 /pmc/articles/PMC3145799/ /pubmed/21857817 http://dx.doi.org/10.1371/journal.ppat.1002164 Text en Cancian et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Cancian, Laila
Bosshard, Rachel
Lucchesi, Walter
Karstegl, Claudio Elgueta
Farrell, Paul J.
C-Terminal Region of EBNA-2 Determines the Superior Transforming Ability of Type 1 Epstein-Barr Virus by Enhanced Gene Regulation of LMP-1 and CXCR7
title C-Terminal Region of EBNA-2 Determines the Superior Transforming Ability of Type 1 Epstein-Barr Virus by Enhanced Gene Regulation of LMP-1 and CXCR7
title_full C-Terminal Region of EBNA-2 Determines the Superior Transforming Ability of Type 1 Epstein-Barr Virus by Enhanced Gene Regulation of LMP-1 and CXCR7
title_fullStr C-Terminal Region of EBNA-2 Determines the Superior Transforming Ability of Type 1 Epstein-Barr Virus by Enhanced Gene Regulation of LMP-1 and CXCR7
title_full_unstemmed C-Terminal Region of EBNA-2 Determines the Superior Transforming Ability of Type 1 Epstein-Barr Virus by Enhanced Gene Regulation of LMP-1 and CXCR7
title_short C-Terminal Region of EBNA-2 Determines the Superior Transforming Ability of Type 1 Epstein-Barr Virus by Enhanced Gene Regulation of LMP-1 and CXCR7
title_sort c-terminal region of ebna-2 determines the superior transforming ability of type 1 epstein-barr virus by enhanced gene regulation of lmp-1 and cxcr7
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3145799/
https://www.ncbi.nlm.nih.gov/pubmed/21857817
http://dx.doi.org/10.1371/journal.ppat.1002164
work_keys_str_mv AT cancianlaila cterminalregionofebna2determinesthesuperiortransformingabilityoftype1epsteinbarrvirusbyenhancedgeneregulationoflmp1andcxcr7
AT bosshardrachel cterminalregionofebna2determinesthesuperiortransformingabilityoftype1epsteinbarrvirusbyenhancedgeneregulationoflmp1andcxcr7
AT lucchesiwalter cterminalregionofebna2determinesthesuperiortransformingabilityoftype1epsteinbarrvirusbyenhancedgeneregulationoflmp1andcxcr7
AT karsteglclaudioelgueta cterminalregionofebna2determinesthesuperiortransformingabilityoftype1epsteinbarrvirusbyenhancedgeneregulationoflmp1andcxcr7
AT farrellpaulj cterminalregionofebna2determinesthesuperiortransformingabilityoftype1epsteinbarrvirusbyenhancedgeneregulationoflmp1andcxcr7